secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytek Biosciences, Inc. (CTKB)
CIK:        0001831915
Form:       8-K
Filed at:   2022-01-06T23:59:59+00:00
Accession:  0001193125-22-003544
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cytek Biosciences appoints Dr. Vera Imper to board of directors
---------------------------------------------------------------

- Board expanded from six to seven members; Dr. Imper appointed as Class II director effective Dec 31, 2021.
- Dr. Imper receives $40,000 annual retainer and initial equity award of $300,000 (28,598 option shares at $16.32).
- Initial options vest monthly over three years; annual equity grant of $160,000 at 2022 annual meeting.
- Dr. Imper determined independent under Nasdaq rules; standard indemnification agreement in place.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831915/000119312522003544/0001193125-22-003544-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831915/000119312522003544/d284047d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-003544

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer